Molecular analyses and prognostic relevance of HPV in head and neck tumours

Oncology Reports

Volumn 17, Issue 4, 2007, Pages 931-939

  Badaracco, Gianna ^a   Rizzo, Consuelo ^a   Mafera, Barbara ^a,b   Pichi, Barbara ^a   Giannarelli, Diana ^a   Rahimi, Siavash S ^b   Vigili, Maurizio G ^b   Venuti, Aldo ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

E6 E7 transcription; Head and neck tumour; HPV; Integration; Prognosis

Indexed keywords

VIRUS DNA; VIRUS RNA;

ALPHAPAPILLOMAVIRUS; ARTICLE; FEMALE; GENETICS; GENOTYPE; HEAD AND NECK TUMOR; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL; VIROLOGY; VIRUS CELL TRANSFORMATION;

ALPHAPAPILLOMAVIRUS; CELL TRANSFORMATION, VIRAL; DNA, VIRAL; FEMALE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RNA, VIRAL; SURVIVAL ANALYSIS;

EID: 34249302182     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.4.931     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Franceschi S, Bidoli E, Herrero R and Munoz N: Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 36: 106-115, 2000.
3. IARC Working group: IARC Monographs on the evaluation of carcinogenic risks to humans. Human Papillomaviruses. IARC Scientific Publication 64, International Agency for Research on Cancer, Lyon, 1995.
4. Kreimer AR, Clifford GM, Boyle P and Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475, 2005. (Pubitemid 40270113)
5. Fakhry C and Gillison ML: Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 24: 2606-2611, 2006. (Pubitemid 46622080)
6. Venuti A, Manni V, Morello R, De Marco F, Marzetti F and Marcante ML: Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 60: 396-402, 2000. (Pubitemid 30127310)
7. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB and Brakenhoff RH: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93: 232-235, 2001. (Pubitemid 32574279)
8. Wiest T, Schwartz E, Enders C, Flechtenmacher C and Bosch FX: Involvement of intact HPV 16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21: 1510-1517, 2002. (Pubitemid 34226138)
9. Badaracco G, Venuti A, Morello R, Muller A and Marcante ML: Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res 20: 1301-1306, 2000.
10. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M and Dalianis T: Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102: 152-158, 2002.
11. Koskinen WJ, Chen RW, Leivo I, Makitie A, Back L, Kontio R, Suuronen R, Lindqvist C, Auvinen E, Molijn A, Quint WG, Vaheri A and Aaltonen LM: Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 107: 401-406, 2003. (Pubitemid 37266460)
12. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ and Fuchs PG: Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92: 2875-2884, 2001.
13. Schlecht NF: Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence: Oncol Rep 14: 1239-1247, 2005.
14. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S and Vigili MG: Presence of HPV in head and neck tumours: high prevalence in tonsillar localization, J Exp Clin Cancer Res 23: 561-566, 2004.
15. Badaracco G, Venuti A, Sedati A and Marcante ML: HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol 67: 574-582, 2002. (Pubitemid 34747680)
16. Yoshinouchi M, Hongo A, Nakamura K, Kodama J, Itoh S, Sakai H and Kudo T: Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers. J Clin Microbiol 37: 3514-3517, 1999. (Pubitemid 29491084)
17. Rector A, Tachezy R and Van Ranst M: A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification. J Virol 78: 4993-4998, 2004. (Pubitemid 38581449)
18. Sasagawa T, Minemoto Y, Basha W, Yamazaki H, Nakamura M, Yoshimoto H, Sakaike J and Inoue M: A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV). Virus Res 67: 127-139, 2000. (Pubitemid 30365166)
19. Biswas C, Kell B, Mant C, Jewers RJ, Cason J, Muir P, Raju KS and Best JM: Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology. J Clin Microbiol 35: 1560-1564, 1997. (Pubitemid 27216833)
20. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P and von Knebel Doeberitz M: Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132-6136, 1999. (Pubitemid 30035633)
21. Miguel RE, Villa LL, Cordeiro AC, Prado JC, Sobrinho J and Kowalski LP: Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer. Am J Surg 176: 428-429, 1998. (Pubitemid 29021541)
22. Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D and Califano JA: Real-time quantitative PCR demonstrates low prevalence of HPV 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 8: 1203-1209, 2002. (Pubitemid 34517659)
23. Li W, Thompson CH, Xin D, Cossart YE, O'Brien CJ, McNeil EB, Gao K, Scolyer RA and Rose BR: Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol 163: 2185-2192, 2003.
24. Li W, Thompson CH, Cossart YE, O'Brien CJ, Liu J, Scolyer RA, Carter JR, Dalrymple C and Rose BR: The site of infection and ethnicity of the patient influence the biological pathways to HPV-induced mucosal cancer. Mod Pathol 17: 1031-1037, 2004. (Pubitemid 39128228)
25. Syrjanen S: Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 32S: S59-S66, 2005.
26. Herrero R: Chapter 7: Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst Monographs 31: 47-51, 2003.
27. Snijders PJ, Meijer CJ, van den Brule AJ, Schrijnemakers HF, Snow GB and Walboomers JM: Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. J Gen Virol 73: 2059-2066, 1992.
28. Ragin CC, Reshmi SC and Gollin SM: Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 110: 701-709, 2004. (Pubitemid 38746029)
29. Hafkamp HC, Manni JJ and Speel EJ: Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol 124: 520-526, 2004. (Pubitemid 38797618)